DCN and cancer: In asthma, decorin potentiates IFNγ activity32,33, such that decorin-deficient mice have reduced lung tissue inflammation21, while in cancer, it has anti-oncogenic properties, including the prevention of metastatic spread and angiogenesis34–36.